These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7985683)

  • 1. Stavudine approved under accelerated drug-approval process.
    Am J Hosp Pharm; 1994 Sep; 51(17):2087. PubMed ID: 7985683
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA looks at full approval for d4T. Food and Drug Administration.
    Posit Aware; 1996; 7(1):7. PubMed ID: 11363131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA notifications. FDA approved 3 generic formulations of stavudine.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19219951
    [No Abstract]   [Full Text] [Related]  

  • 4. Generic stavudine approved.
    AIDS Patient Care STDS; 2009 May; 23(5):396-7. PubMed ID: 19422067
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA notifications. Tentative approval for generic stavudine, oral solution.
    AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415959
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA notifications. FDA approves generic stavudine.
    AIDS Alert; 2009 Mar; 24(3):34. PubMed ID: 19441156
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA notifications. FDA grants tentative approval to two ART drugs under expedited review.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580369
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA notifications. Generic stavudine and efavirenz are tentatively approved by FDA.
    AIDS Alert; 2008 Apr; 23(4):46. PubMed ID: 19253455
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA notifications. Tentative approval granted for lamivudine/stavudine.
    AIDS Alert; 2008 Aug; 23(8):92-3. PubMed ID: 18727174
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA notifications. NRTI Emtriva receives FDA approval.
    AIDS Alert; 2003 Oct; 18(10):131-2. PubMed ID: 14686301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three generic stavudine formulations approved.
    AIDS Patient Care STDS; 2009 Feb; 23(2):135. PubMed ID: 19236160
    [No Abstract]   [Full Text] [Related]  

  • 12. Tenofovir: Gilead applies for approval; expanded access liberalized.
    Gilden D
    AIDS Treat News; 2001 May; (364):2-3, 1. PubMed ID: 11569959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Committee recommends approval of AIDS drug.
    Minn Med; 1994 Jul; 77(7):55. PubMed ID: 8052209
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging drugs in the fight against HIV disease.
    Rosenthal E
    HRSA Careaction; 2003 Feb; ():1-8. PubMed ID: 12739497
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. FDA gives tentative approval for stavudine, lamivudine & nevirapine tablet.
    AIDS Alert; 2009 Sep; 24(9):105-6. PubMed ID: 19938312
    [No Abstract]   [Full Text] [Related]  

  • 16. Reyataz dosing options discussed. Excerpts from the FDA atazanavir hearing.
    Huff B
    GMHC Treat Issues; 2003 Jun; 17(6):8-11. PubMed ID: 12913962
    [No Abstract]   [Full Text] [Related]  

  • 17. New drug applications sought.
    AIDS Alert; 1995 Sep; 10(9):119-20. PubMed ID: 11362777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA approves d4T as alternative to AZT, ddI, or ddC. Food and Drug Administration.
    Friedland G
    AIDS Clin Care; 1995 Jan; 7(1):4, 10. PubMed ID: 11362162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of the drug approval process.
    Martinez LJ
    Res Initiat Treat Action; 2002; 8(1):11-7. PubMed ID: 12489521
    [No Abstract]   [Full Text] [Related]  

  • 20. Kaletra (ABT-378/r) approved.
    James JS
    AIDS Treat News; 2000 Sep; (351):2-3. PubMed ID: 12173550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.